Roble Belko & Company’s Acadia Healthcare ACHC Stock Holding History

Roble Belko & Company’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Hold	40	–	–	﹤0.01%	409
2026 Q1	$1K	Hold	40	–	–	﹤0.01%	407
2025 Q4	$1K	Hold	40	–	–	﹤0.01%	406
2025 Q3	$1K	Hold	40	–	–	﹤0.01%	370
2025 Q2	$1K	Hold	40	–	–	﹤0.01%	347
2025 Q1	$1K	Hold	40	–	–	﹤0.01%	338
2024 Q4	$2K	Hold	40	–	–	﹤0.01%	302
2024 Q3	$3K	Hold	40	–	–	﹤0.01%	273
2024 Q2	$3K	Hold	40	–	–	﹤0.01%	274
2024 Q1	$3K	Hold	40	–	–	﹤0.01%	275
2023 Q4	$3K	Hold	40	–	–	﹤0.01%	273
2023 Q3	$3K	Buy	+40	New	+$2.99K	﹤0.01%	245
2017 Q2	–	Sell	-262	Closed	-$11K	–	297
2017 Q1	$11K	Hold	262	–	–	0.01%	179
2016 Q4	$9K	Buy	+262	New	+$10.2K	﹤0.01%	211

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Roble Belko & Company's ACHC Position: Q2 2026 in Review

Roble Belko & Company held its Acadia Healthcare (ACHC) position steady in Q2 2026 at 40 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #409.

Roble Belko & Company first reported a position in ACHC in Q4 2016 and has held it in 14 quarters since. The position peaked at $11K in Q1 2017. 313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

Roble Belko & Company held 40 shares of Acadia Healthcare worth $1K as of Q2 2026.
Roble Belko & Company left its Acadia Healthcare share count unchanged in Q2 2026.
Acadia Healthcare made up ﹤0.01% of Roble Belko & Company's portfolio in Q2 2026, its #409 holding.
Roble Belko & Company first reported a position in Acadia Healthcare in Q4 2016 and has held it in 14 quarters since.
Roble Belko & Company's Acadia Healthcare position peaked at $11K in Q1 2017.
313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.